Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adolor Corporation
Dr. Eliseo Oreste Salinas to Join Adolor Corporation as Senior Vice President Research & Development and Chief Medical Officer
May 4th, 2008
Adolor Corporation (Nasdaq:ADLR) announced that Eliseo Oreste Salinas, MD, MSc, will join Adolor as senior vice president research and development and chief medical officer. Dr. Salinas will commence his employment with Adolor on June 2, 2008 and will report to Michael R. Dougherty, president & chief executive officer, Adolor Corporation. "We are extremely pleased that Eliseo will be joining the Adolor team," said Mr. Dougherty. "His extensive CNS research and clinical development experience will be of tremendous benefit to Adolor as we advance our promising portfolio of novel pain management programs." Dr. Salinas has more than fifteen years of...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-04)
|
